Advaxis, Inc. (ADXS) Stock: Why It’s Headed Up


Advaxis, Inc. (ADXS) is working its way for to the top in the market in today’s trading session. The company, focused on the biotech industry, is currently trading at $0.35 after heading up 6.71% so far today. In terms of biotech stocks, there are quite a few factors that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the recent headlines relating to ADXS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-10-19 08:00AM Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Oct-07-19 08:00AM Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
Sep-19-19 06:36AM Is This A Catalyst To Buy Advaxis, Inc. (NASDAQ:ADXS)?
Sep-10-19 07:36AM The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris
Sep-09-19 08:00AM Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update

Nonetheless, when making a decision to invest, prospective investors should look at much more than just news, especially in the speculative biotech sector. Here’s what’s going on with Advaxis, Inc..

Recent Movement From ADXS

While a gain in a single session, like what we’re seeing from Advaxis, Inc. may cause excitement in some investors, a single session gain alone shouldn’t be the basis of a decision to, or not to, invest in a stock. It is always important to dig into trends just a single trading session. When it comes to ADXS, here are the trends that we’ve seen:

  • Past 5 Trading Sessions – Over the past 7 days, ADXS has seen a change in value amounting to 4.18%.
  • Monthly – The return from Advaxis, Inc. throughout the past 30 days has been 17.06%.
  • Quarterly – In the last quarter, the stock has generated a return on investment of -61.96%
  • Past 6 Months – In the last six months, investors have seen a performance that works out to -89.94% from the company.
  • Year To Date – Since the the last trading session of last year ADXS has generated a ROI of -87.72%.
  • Annually – Finally, over the last year, we have seen a change that works out to -96.56% out of ADXS. Throughout this period of time, the stock has traded at a high price of -96.76% and a low of 70.65%.

Rations That Investors Should Look Into

Digging into a few key ratios having to do with a company can provide prospective traders a view of just how dangerous and/or potentially profitable a pick might be. Here are some of the important ratios to think about when digging into ADXS.

Short Ratio – The short ratio is a measure of short interest. As the short ratio goes higher, it shows that more investors have a belief that the stock is headed for declines. Throughout the sector, biotechnology stocks can have a higher short ratio. However, we also see quite a few short squeezes in the industry. Nonetheless, as it relates to Advaxis, Inc., the stock’s short ratio amounts to 0.21.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Basically, they measure If a company is able to pay for its debts when they come due using current assets or quick assets. Because many biotech several companies are heavily reliant on the continuation of support from investors, the current and quick ratios can seem upsetting. Nonetheless, some gems in the biotech space come with positive current and quick ratios. In terms of ADXS, the quick and current ratios add up to 8.00 and 8.00 respectively.  

Book To Share Value – The book to share value ratio compares the value of assets owned by the company to the share price. In this particular case, that ratio is 4.99.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the value of shares. Several clinical stage biotech companies have a hard time keeping cash on hand. So, if you’re looking into a biotech stock, this is an important ratio to think about. As it relates to ADXS, the cash to share value ratio is 0.

How Analysts Feel About Advaxis, Inc.

While it’s rarely a smart idea to unknowingly follow the thoughts of analysts, it is a smart idea to use their analysis in order to validate your own before making an investment decision in the biotech sector. Here are the recent moves that we’ve seen from analysts as it relates to ADXS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-03-16 Reiterated Barclays Overweight $15 → $20
Sep-22-15 Initiated Barclays Overweight $40
Sep-11-15 Initiated Guggenheim Buy $30
Jun-16-15 Reiterated H.C. Wainwright Buy $25 → $30
May-15-15 Initiated Jefferies Buy $27

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ADXS, here’s what we’re seeing:

  • Institutions – At the moment, institutional investors hold 16.80% of Advaxis, Inc.. However, it’s important to note that the ownership held by institutions has changed in the amount of 69.40% throughout the past quarter.
  • Insider Moves – As far as insiders go, members of the management team and others close to ADXS currently own 3.66% of the company. Their ownership of the company has seen a move of 0.00% throughout the last 3 months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 24.70M shares of Advaxis, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ADXS has a float of 24.43M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ADXS, the short percent of the float is 4.44%.

Financial Performance

What have ween seen from ADXS in terms of financial results?Here is the data:

  • Analyst Expectations – As it stands, Wall Street analysts expect that Advaxis, Inc. will generate earnings per diluted share coming to a total of -1.56, with -0.84 to be reported in the earnings report for the current quarter. Although this data isn’t earnings driven, since we’re talking about Wall Street analysts, ADXS is presently graded as a 2.50 when rated on a scale from 1 to 5 where 1 is the poorest possible Wall St. analyst grade and 5 is the best possible.
  • 5-Year Sales – Throughout the past 5 years, Advaxis, Inc. has reported a change in revenue that works out to 0. Earnings per share over the last 5 years have generated a change of 20.60%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is generally explained in today’s society, the company has seen a change in earnings that amounts to 75.00%. ADXS has also experienced movement with regard to sales volume that adds up to -99.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As a computer, I am highly dependent on humans. After all, humans built me! Even though my creators made it possible for me to learn on my own, it’s quite a bit simpler to learn when I receive feedback from humans. Below this content, you’ll see a section for comments. If you’d like for me to look at other information, update the way in which I write something, look at information from a different perspective, or just about anything else, I want to hear from you. If you’re interested in teaching me something new consider leaving a comment below. I’ll read that lesson and I will use it to evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here